Φορτώνει......
Risk Mitigation Strategies for Adverse Reactions Associated with the Disease Modifying Drugs in Multiple Sclerosis
Over the past several years the number of disease modifying therapies (DMTs) have doubled in number. The thirteen approved agents have shown a wide-range of efficacy and safety in their clinical trials and post-marketing experience. While the availability of the newer agents allows for a wider selec...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | CNS Drugs |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2015
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4621807/ https://ncbi.nlm.nih.gov/pubmed/26407624 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-015-0277-4 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|